WCG Clinical

NOVEMBER 20, 2023

To view it please enter your password below: Password: The post A Review Of The Regulatory Landscape for In Vitro Gametogenesis appeared first on WCG. This content is password protected.

In-Vitro 40

In-Vitro 40

Drug Discovery World

SEPTEMBER 16, 2022

A new In Vitro Pharmacology Working Group to accelerate regulatory submissions has been created by the Pistoia Alliance, a global advocate for greater collaboration in life sciences R&D. The post In Vitro Pharmacology Working Group to address data standards appeared first on Drug Discovery World (DDW).

In-Vitro 52

In-Vitro Drugs Life Science Research 52

Drug Discovery World

AUGUST 9, 2023

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. Participants will gain insight into the specific needs and utility for in vitro ADME and DDI investigations in the drug development process.

In-Vitro 52

In-Vitro Drugs Development 52

Drug Discovery World

MARCH 21, 2023

The In Vitro Diagnostic Regulation (IVDR) came into effect in May 2022. The number of clinical trials delayed is expected to run into the hundreds, affecting up to 42,200 patients over the next three years, according to a survey run by EFPIA. However, this process is currently complex and uncoordinated.

In-Vitro 52

In-Vitro Clinical Trials Clinical Trials Regulation 52

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 1, 2023

The Drug Controller General of India (DCGI) has added in-vitro diagnostic (IVD) medical devices including those for diagnosis of Covid-19, ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) extraction kits, among others into the Class C risk category under the Medical Devices Rules (MDR), 2017.

RNA 163

RNA DNA In-Vitro Drugs 163

Pharmaceutical Technology

APRIL 7, 2023

In vitro data of EDP-323 showed a significant reduction in RSV replication with picomolar potency in primary human bronchial epithelial cells against RSV A and B. Enanta Pharmaceuticals has secured the US Food and Drug Administration’s (FDA) fast track designation for EDP-323 to treat respiratory syncytial virus (RSV).

In-Vitro 276

In-Vitro Bioavailability Drugs Development 276

BioTech 365

JULY 26, 2021

Latin America In-Vitro Diagnostic Tests Research Report 2021 – ResearchAndMarkets.com Latin America In-Vitro Diagnostic Tests Research Report 2021 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “The Market for In Vitro Diagnostic Tests in Latin America” report has been added to ResearchAndMarkets.com’s (..)

In-Vitro 40

In-Vitro Research Marketing 40

Scienmag

NOVEMBER 17, 2020

Researchers at Karolinska Institutet in Sweden report promising results from an in vitro combination therapy against COVID-19. Credit: Martin Stenmark.

In-Vitro 59

In-Vitro Medicine Drugs Trials 59

Pharma Times

OCTOBER 1, 2022

Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine

In-Vitro 143

In-Vitro Vaccination Vaccine Development 143

BioTech 365

AUGUST 9, 2021

Saudi Arabia In-Vitro Diagnostics (IVD) Market Forecast Report 2021-2027 – ResearchAndMarkets.com Saudi Arabia In-Vitro Diagnostics (IVD) Market Forecast Report 2021-2027 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Technology/Technique, Application, End User), (..)

In-Vitro 40

In-Vitro Marketing 40

BioTech 365

OCTOBER 8, 2021

Global In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report 2021 – ResearchAndMarkets.com Global In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report 2021 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global In-vitro Toxicology Testing Market Size, Share & Trends (..)

In-Vitro 40

In-Vitro Marketing 40

Pharma Times

SEPTEMBER 23, 2022

Link up will involve reporting on role of rapid diagnostics in taking on antimicrobial resistance

In-Vitro 123

In-Vitro 123

BioTech 365

NOVEMBER 27, 2020

India In-vitro Fertilization Market Competition, Forecast & Opportunities, 2026 – ResearchAndMarkets.com India In-vitro Fertilization Market Competition, Forecast & Opportunities, 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “India In-vitro Fertilization Market By Technique (ICSI IVF v/s Non-ICSI/ (..)

In-Vitro 40

In-Vitro Marketing Production 40

BioTech 365

JANUARY 28, 2022

Specifica Validates Best-in-Class Status for in vitro Antibody Discovery Platform in Two Key Peer Reviewed Publications Specifica Validates Best-in-Class Status for in vitro Antibody Discovery Platform in Two Key Peer Reviewed Publications SANTA FE, N.M.–(BUSINESS

In-Vitro 52

In-Vitro Antibody 52

BioTech 365

MAY 17, 2021

PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment WALTHAM, Mass.–(BUSINESS

In-Vitro 52

In-Vitro 52

BioTech 365

NOVEMBER 18, 2021

Algenex and Biokit renew licensing agreement for insect-based production of human in vitro diagnostics Algenex and Biokit renew licensing agreement for insect-based production of human in vitro diagnostics PRESS RELEASE Algenex and Biokit renew licensing agreement for insect-based production of … Continue reading →

In-Vitro 40

In-Vitro Licensing Licensing Production 40

Bio Pharma Dive

OCTOBER 24, 2022

BioPharma Dive’s Delilah Alvarado worked with reporters from Healthcare Dive to examine the impact of state laws banning abortion on people trying to conceive via in vitro fertilization.

In-Vitro 189

In-Vitro 189

BioTech 365

JUNE 21, 2021

Europe In-Vitro Diagnostics Market Forecast Report 2021-2027: Increasing Adoption and Popularity of Automation in Clinical Laboratories – ResearchAndMarkets.com Europe In-Vitro Diagnostics Market Forecast Report 2021-2027: Increasing Adoption and Popularity of Automation in Clinical Laboratories – ResearchAndMarkets.com DUBLIN–(BUSINESS (..)

In-Vitro 40

In-Vitro Marketing 40

Medical Xpress

MARCH 1, 2023

In the worst-case scenario, getting chemicals in your eyes can lead to blindness. Until now, the eye irritancy potential of chemical substances has had to be assessed using the Draize test on live rabbits—a standard implemented worldwide.

In-Vitro 92

In-Vitro 92

BioTech 365

OCTOBER 14, 2021

Announces Publication of In Vitro Test Results Assessing Betadine® Formulations Against Four Coronaviruses Avrio Health L.P. Announces Publication of In Vitro Test Results Assessing Betadine® Formulations Against Four Coronaviruses Betadine® antiseptic products have not been demonstrated to … Continue reading →

In-Vitro 40

In-Vitro Production 40

Pharmaceutical Technology

MAY 4, 2023

The approval allows KALYDECO to be used in infants who have at least one mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to the therapy, on the basis of clinical and/or in vitro assay results. This cohort showed a safety profile identical to that found in older children and adults.

Genetic Disease 246

Genetic Disease In-Vitro Medicine Gene 246

BioTech 365

JULY 30, 2021

Worldwide In-vitro Transcription Templates Industry to 2030 – by Disease, Treatment, Research Stage, End-user and Region – ResearchAndMarkets.com Worldwide In-vitro Transcription Templates Industry to 2030 – by Disease, Treatment, Research Stage, End-user and Region – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The (..)

In-Vitro 40

In-Vitro Research 40

Drug Discovery World

OCTOBER 23, 2023

Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations , which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. The effect of several variables on the IVT reaction using different size DNA templates was assessed.

In-Vitro 52

In-Vitro Reagent Production DNA 52

BioTech 365

JULY 22, 2021

ImmunoPrecise’s PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays ImmunoPrecise’s PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays IPA publishes its scientific paper “Cornering an Ever-Evolving Coronavirus: (..)

In-Vitro 40

In-Vitro Antibody 40

BioTech 365

MARCH 4, 2021

China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93 Billion – ResearchAndMarkets.com China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93

In-Vitro 40

In-Vitro Marketing 40

Medical Xpress

MAY 16, 2023

That was the case when Thilini Gamage was to carry out one of the studies in her doctoral work with Professor Eirik Frengen at the Institute of Clinical Medicine, University of Oslo. They study gene variation and mutations that cause rare genetic diseases. A mutation is a permanent change in the genetic material.

In-Vitro 98

In-Vitro Genetic Disease In-Vivo Genetics 98

BioTech 365

FEBRUARY 10, 2021

Leading Innovators Collaborate to Provide New, Patient Representative Cell Culture Solutions for Smarter In Vitro Research. Leading Innovators Collaborate to Provide New, Patient Representative Cell Culture Solutions for Smarter In Vitro Research. Cellaria Inc and BioLamina pool expertise to support … Continue reading →

In-Vitro 52

In-Vitro Research 52

Pharmaceutical Technology

APRIL 27, 2023

The treatment is now indicated for CF patients with a minimum of one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, or with a mutation in the CFTR gene that responds to Trikafta based on in vitro data. It was previously approved to treat CF in children aged between six and 11 years.

FDA Approval 246

FDA Approval Drugs In-Vitro Gene 246

BioTech 365

JUNE 1, 2021

North America In-Vitro Diagnostics Market Forecast to 2027 by Product and Services; Technology; Application; End User – ResearchAndMarkets.com North America In-Vitro Diagnostics Market Forecast to 2027 by Product and Services; Technology; Application; End User – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “North (..)

In-Vitro 40

In-Vitro Production Marketing 40

BioTech 365

MAY 24, 2021

Synairgen announces results of in vitro studies showing antiviral activity of interferon beta against key SARS-CoV-2 variants Synairgen announces results of in vitro studies showing antiviral activity of interferon beta against key SARS-CoV-2 variants Press release Synairgen plc(‘Synairgen’ or the … Continue reading →

In-Vitro 40

In-Vitro 40

BioTech 365

JULY 27, 2021

In-Vitro Fertilization Market is Expected to Grow at a CAGR of 5.45% During the Period 2021-2026. In-Vitro Fertilization Market is Expected to Grow at a CAGR of 5.45% During the Period 2021-2026. – ResearchAndMarkets.com U.S. – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … Continue reading →

In-Vitro 40

In-Vitro Marketing 40

BioTech 365

SEPTEMBER 29, 2021

Shionogi to Present In Vitro and Real-World Data at IDWeek 2021 Demonstrating Activity of FETCROJA® (cefiderocol) Against Gram-Negative Pathogens Shionogi to Present In Vitro and Real-World Data at IDWeek 2021 Demonstrating Activity of FETCROJA® (cefiderocol) Against Gram-Negative Pathogens OSAKA, Japan–(BUSINESS … Continue reading → (..)

In-Vitro 52

In-Vitro 52

Medical Xpress

MARCH 27, 2023

Cardiotoxicity is a clinical condition that arises from using pharmaceutical agents such as antibiotics, which result in harmful effects on the heart, ultimately compromising its functional capacity. The left ventricle's contractile ability is impaired, potentially leading to heart failure, a severe clinical outcome.

In-Vitro 75

In-Vitro Drugs Engineer Research 75

BioTech 365

JANUARY 13, 2022

Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2; Commencement of Trading as a Public Company REPEAT — Revelation Biosciences Inc. Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2; Commencement of Trading … Continue reading →

In-Vitro 40

In-Vitro 40

Pharma Mirror

SEPTEMBER 2, 2021

In-vitro studies conducted at the British virology research laboratory Virology Research Services in London then demonstrated a potent antiviral activity against SARS-CoV-2 and other RNA viruses. Code Pharma discovered that the peptide had a direct antiviral effect against SARS-CoV-2, the novel Coronavirus causing COVID-19.

In-Vitro 245

In-Vitro Clinical Trials Clinical Trials RNA 245

BioTech 365

JANUARY 18, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Scientists produce the first in-vitro embryos from vitrified African lion oocytes.A

In-Vitro 40

In-Vitro Scientist Research 40

BioTech 365

MARCH 29, 2021

Insights on the In-vitro Diagnostics Global Market to 2027 – Development of Condition-Specific Markers and Tests Presents Opportunities – ResearchAndMarkets.com Insights on the In-vitro Diagnostics Global Market to 2027 – Development of Condition-Specific Markers and Tests Presents Opportunities – ResearchAndMarkets.com … (..)

In-Vitro 40

In-Vitro Development Marketing 40